James Paul Lang - 05 Jan 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Jan 2026, 17:00:32 UTC
Prior SEC filing
06 Jan 2026
Next SEC filing
07 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joanne Wendy Kim, attorney-in-fact for James Lang

Key filing fact

James Paul Lang filed Form 4 for BIOVIE INC. (BIVI) on 09 Jan 2026.

Key facts

  • This page summarizes James Paul Lang's Form 4 filing for BIOVIE INC. (BIVI).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Jan 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 06 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001703090 Primary reporting owner

Lang James Paul

Relationship
Director
Address
C/O BIOVIE INC., 680 W NYE LANE STE 201, CARSON CITY
Signature
/s/ Joanne Wendy Kim, attorney-in-fact for James Lang
Signature date
09 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIVI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+90,000
Change %
Price
$0.000000
Shares after
90,000
Date
05 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
90,000
Exercise price
$1.31
Footnotes
F1
BIVI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+330,500
Change %
Price
$0.000000
Shares after
330,500
Date
05 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
330,500
Exercise price
$1.31
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.

Footnote F2

75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .